Major Biopharm Company Plans Massive Expansion – Credits Big, Beautiful Bill

This post was originally published on here Amgen (NASDAQ: AMGN) is a major player in biotech and biopharmaceuticals. They’re in the top 20 of biomedical companies by revenue, with over $33 billion in revenue in 2024. Despite California’s increasingly hostile work environment, Amgen maintains its primary operation at its Thousand Oaks, California headquarters. Amgen isn’t…